Where does Lincoln Pharmaceuticals make most of its revenue?

Rest of World: 62% of revenue by region in fiscal year 2025, followed by India (38%).

What companies are similar to Lincoln Pharmaceuticals?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sakar Healthcare Limited (SAKAR.NS), Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS), Bharat Parenterals Ltd (BPLPHARMA.BO), Bafna Pharmaceuticals Limited (BAFNAPH.NS).

Lincoln Pharmaceuticals Limited (LINCOLN.NS) Stock

About Lincoln Pharmaceuticals Limited

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, anti-infective, anti-bacterial, gynecology, cardio and CNS, respiratory ...

At a glance

In Q3 2026 (the quarter ended December 31, 2025) revenue was 1.66 billion INR, up 13.5% from a year before. Rest of World was its largest region in fiscal year 2025, with 62% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.